Natural Products for the Management and Prevention of Breast Cancer

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2018 Apr 24

PMID 29681985

Citations 75

Authors

Sarmistha Mitra

Raju Dash

Affiliations

Soon will be listed here.

Abstract

Among all types of cancer, breast cancer is one of the most challenging diseases, which is responsible for a large number of cancer related deaths. Hormonal therapy, surgery, chemotherapy, and radiotherapy have been used as treatment of breast cancer, for a very long time. Due to severe side effects and multidrug resistance, these treatment approaches become increasingly ineffective. However, adoption of complementary treatment approach can be a big solution for this situation, as it is evident that compounds derived from natural source have a great deal of anticancer activity. Natural compounds can fight against aggressiveness of breast cancer, inhibit cancerous cell proliferation, and modulate cancer related pathways. A large number of research works are now focusing on the natural and dietary compounds and trying to find out new and more effective treatment strategies for the breast cancer patients. In this review, we discussed some significant natural chemical compounds with their mechanisms of actions, which can be very effective against the breast cancer and can be more potent by their proper modifications and further clinical research. Future research focusing on the natural anti-breast-cancer agents can open a new horizon in breast cancer treatment, which will play a great role in enhancing the survival rate of breast cancer patients.

Citing Articles

The interplay of exercise and green tea: a new road in cancer therapy.

Liu B, Tian H, Momeni M Cancer Cell Int. 2025; 25(1):6.

PMID: 39773739 PMC: 11705833. DOI: 10.1186/s12935-024-03632-7.

Integrating computational methods and experimental validation reveals the pharmacological mechanism of (L.) Baker targeting major proteins in breast cancer.

Awadelkareem A, Patel M, Banu H, Adnan M Heliyon. 2024; 10(19):e38801.

PMID: 39430520 PMC: 11489316. DOI: 10.1016/j.heliyon.2024.e38801.

Novel Anti-tumor Strategy for Breast Cancer: Synergistic Role of Oleuropein with Paclitaxel Therapeutic in MCF-7 Cells.

Yilmaz G, Ozdemir F Anticancer Agents Med Chem. 2024; 24(3):224-234.

PMID: 38629155 PMC: 10909830. DOI: 10.2174/0118715206284107231120063630.

Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures.

Boulifa A, Raftery M, Franzen A, Radecke C, Stintzing S, Blohmer J BMC Cancer. 2024; 24(1):339.

PMID: 38486205 PMC: 10938759. DOI: 10.1186/s12885-024-11979-3.

Sinensetin suppresses breast cancer cell progression via Wnt/β-catenin pathway inhibition.

Zhu S, Meng L, Wei P, Gu G, Duan K Transl Cancer Res. 2024; 13(1):348-362.

PMID: 38410229 PMC: 10894327. DOI: 10.21037/tcr-23-1317.

References

Fumoleau P, Largillier R, Clippe C, Dieras V, Orfeuvre H, Lesimple T . Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. Eur J Cancer. 2004; 40(4):536-42. DOI: 10.1016/j.ejca.2003.11.007. View

Maggiolini M, Bonofiglio D, Pezzi V, Carpino A, Marsico S, Rago V . Aromatase overexpression enhances the stimulatory effects of adrenal androgens on MCF7 breast cancer cells. Mol Cell Endocrinol. 2002; 193(1-2):13-8. DOI: 10.1016/s0303-7207(02)00091-6. View

Thomson C, Chow H, Wertheim B, Roe D, Stopeck A, Maskarinec G . A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen. Breast Cancer Res Treat. 2017; 165(1):97-107. PMC: 5571834. DOI: 10.1007/s10549-017-4292-7. View

Cuendet M, Pezzuto J . The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol Drug Interact. 2001; 17(1-4):109-57. DOI: 10.1515/dmdi.2000.17.1-4.109. View

Jackson S, Singletary K . Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization. Carcinogenesis. 2003; 25(2):219-27. DOI: 10.1093/carcin/bgg192. View

Qin W, Zhang K, Clarke K, Weiland T, Sauter E . Methylation and miRNA effects of resveratrol on mammary tumors vs. normal tissue. Nutr Cancer. 2014; 66(2):270-7. DOI: 10.1080/01635581.2014.868910. View

Aggarwal B, Shishodia S, Takada Y, Banerjee S, Newman R, Bueso-Ramos C . Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res. 2005; 11(20):7490-8. DOI: 10.1158/1078-0432.CCR-05-1192. View

Bishayee A . Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res (Phila). 2009; 2(5):409-18. DOI: 10.1158/1940-6207.CAPR-08-0160. View

Tominaga Y, Wang A, Wang R, Wang X, Cao L, Deng C . Genistein inhibits Brca1 mutant tumor growth through activation of DNA damage checkpoints, cell cycle arrest, and mitotic catastrophe. Cell Death Differ. 2006; 14(3):472-9. DOI: 10.1038/sj.cdd.4402037. View

10.

Jenkins S, Betancourt A, Wang J, Lamartiniere C . Endocrine-active chemicals in mammary cancer causation and prevention. J Steroid Biochem Mol Biol. 2011; 129(3-5):191-200. DOI: 10.1016/j.jsbmb.2011.06.003. View

11.

Sehdev V, Lai J, Bhushan A . Biochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells. J Oncol. 2010; 2009:121458. PMC: 2821773. DOI: 10.1155/2009/121458. View

12.

Jiang X, Zhao Y, Smith C, Gasparetto M, Turhan A, Eaves A . Chronic myeloid leukemia stem cells possess multiple unique features of resistance to BCR-ABL targeted therapies. Leukemia. 2007; 21(5):926-35. DOI: 10.1038/sj.leu.2404609. View

13.

Dharmappa K, Mohamed R, Shivaprasad H, Vishwanath B . Genistein, a potent inhibitor of secretory phospholipase A2: a new insight in down regulation of inflammation. Inflammopharmacology. 2009; 18(1):25-31. DOI: 10.1007/s10787-009-0018-8. View

14.

Dandawate P, Subramaniam D, Jensen R, Anant S . Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy. Semin Cancer Biol. 2016; 40-41:192-208. PMC: 5565737. DOI: 10.1016/j.semcancer.2016.09.001. View

15.

Licznerska B, Szaefer H, Murias M, Bartoszek A, Baer-Dubowska W . Modulation of CYP19 expression by cabbage juices and their active components: indole-3-carbinol and 3,3'-diindolylmethene in human breast epithelial cell lines. Eur J Nutr. 2012; 52(5):1483-92. PMC: 3715682. DOI: 10.1007/s00394-012-0455-9. View

16.

Heinonen S, Wahala K, Adlercreutz H . Identification of urinary metabolites of the red clover isoflavones formononetin and biochanin A in human subjects. J Agric Food Chem. 2004; 52(22):6802-9. DOI: 10.1021/jf0492767. View

17.

Newman D, Cragg G . Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod. 2016; 79(3):629-61. DOI: 10.1021/acs.jnatprod.5b01055. View

18.

Zong H, Wang F, Fan Q, Wang L . Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways. Mol Biol Rep. 2011; 39(4):4803-8. DOI: 10.1007/s11033-011-1273-5. View

19.

Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar S . Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol Cell Biochem. 2006; 296(1-2):85-95. DOI: 10.1007/s11010-006-9302-8. View

20.

Burstein H, Gelber S, Guadagnoli E, Weeks J . Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999; 340(22):1733-9. DOI: 10.1056/NEJM199906033402206. View